Emtricitabine

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Emtricitabine and local guidelines before prescribing.

Nucleoside analogue antiviral

Mechanism

Nucleoside reverse transcriptase inhibitor.

Uses

HIV infection and pre-exposure prophylaxis (with tenofovir).

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Headache, diarrhoea, nausea, skin discolouration, hepatitis B flare on stopping.

Interactions

Nephrotoxic drugs.

Contraindications and cautions

Hypersensitivity

Monitoring

Renal function, HBV

Pregnancy and breastfeeding

Acceptable

Renal and hepatic impairment

Reduce dose if CrCl below 30

Overdose and reversal

Supportive

Special advice

Check HBV status before stopping.

More from the textbook: uses, cautions and other points
Where it is discussed in the book